A Wharton School team is looking at whether GLP-1 medications change impulses around shopping, gambling and other money decisions.
Recap by typeshit. Post by Facebook on Facebook.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
The weight loss drug class started with a lizard. A short local feature looks at how the Gila monster led researchers to GLP-1 medicines.
Healio
At the Cardiometabolic Health Congress, the UAB professor asked whether maximal weight loss is optimal and flagged that most non-diabetic patients quit GLP-1s within two years.
Engel, 63, says he lost sight in both eyes from NAION after starting Ozempic in 2023. His suit claims weak warnings, though a causal link hasn't been established.
Engel, 63, lost sight in both eyes to NAION and says he was never warned. Hundreds of similar suits are pending, though a causal link hasn't been proven.
Loading…